Acyclic nucleoside phosphonate diesters
US-9629860-B2 · Apr 25, 2017 · US
Nucleotide analogs
US12350274B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12350274-B2 |
| Application number | US-202117523806-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 10, 2021 |
| Priority date | Sep 15, 2014 |
| Publication date | Jul 8, 2025 |
| Grant date | Jul 8, 2025 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Disclosed herein, inter alia, are acyclic nucleotide analogs and methods of using an acyclic nucleotide analog for treating and/or ameliorating a papillomavirus infection.
First claim
Opening claim text (preview).
What is claimed is: 1. A compound with the following structure: or a pharmaceutically acceptable salt thereof.
Assignees
Inventors
Classifications
Medicinal preparations containing organic active ingredients · CPC title
the ring phosphorus atom and, at least, one ring oxygen atom being part of a (thio)phosphonic acid derivative · CPC title
Phosphorous; Compounds thereof · CPC title
condensed with carbocyclic or heterocyclic rings or ring systems · CPC title
non-condensed with carbocyclic rings or heterocyclic rings or ring systems · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US12350274B2 cover?
- Disclosed herein, inter alia, are acyclic nucleotide analogs and methods of using an acyclic nucleotide analog for treating and/or ameliorating a papillomavirus infection.
- Who is the assignee on this patent?
- Univ California, Us Gov Veterans Affairs
- What technology area does this patent fall under?
- Primary CPC classification A61K31/522. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jul 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).